Full metadata record
DC FieldValueLanguage
dc.contributor.authorAtaeinia, Bahar-
dc.contributor.authorLoberg, Christina-
dc.contributor.authorKravets, Hanna-
dc.contributor.authorBeheshti, Mohsen-
dc.contributor.authorvon Mallek, Dirk-
dc.contributor.authorMottaghy, Felix M.-
dc.contributor.authorHeinzel, Alexander-
dc.date.accessioned2020-05-25T13:49:42Z-
dc.date.available2020-05-25T13:49:42Z-
dc.date.issued2019-05-21-
dc.identifier.issn1611-2156-
dc.identifier.urihttp://hdl.handle.net/2003/39139-
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-21057-
dc.description.abstractWe present the case of a 77 year old male patient with metastatic pancreatic neuroendocrine tumor (NET). The patient was initially treated by extensive surgical resection that however, led to severe complications with delayed recovery. During follow-up, a number of new liver metastases were detected, one of which was in segment I with impending compression of the inferior vena cava. Due to age and general condition of the patient, instead of further surgical treatment, the patient received four cycles of 177Lu-DOTATOC resulting in an overall partial response with successful tumor reduction in liver segment I, resolving an impending compression of vena cava.en
dc.language.isoen-
dc.relation.ispartofseriesEXCLI Journal;Vol. 18. 2019, p.273-276-
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/-
dc.subjectneuroendocrine tumorsen
dc.subjectmetastasisen
dc.subjectPRRTen
dc.subject177 Lu-DOTATOCen
dc.subject.ddc610-
dc.titleSuccessful palliative peptide receptor radionuclide therapy for impending compression of vena cava due to unresectable liver metastasis of neuroendocrine tumoren
dc.typeText-
dc.type.publicationtypearticle-
dcterms.accessRightsopen access-
eldorado.dnb.zdberstkatid2132560-1-
eldorado.secondarypublicationtrue-
Appears in Collections:Case Reports

Files in This Item:
File Description SizeFormat 
Heinzel_21052019_proof.pdfDNB221.35 kBAdobe PDFView/Open


This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons